PVT1 and cancer: Also, targeting each of HAT1, PVT1, miR-619-5p, and EZH2 individually or in combination may enhance the cancer cells’ resistance to gemcitabine and increase the effects of chemotherapy and prognosis in patients (31, 56, 57).